Author

Hugo De La Peña

Observed names: De La Pena, H, H Pena, H. De La Pena, H. Pena, Hugo De La Pena, Hugo De La Pena Gomez, Hugo De La Peña

Observed institutions: University of Cambridge, Queen Elizabeth Hospital Birmingham, Anthony Nolan, The Royal Free Hospital, Churchill Hospital, University Hospital Southampton NHS Foundation Trust, University of Oxford, Oxford University Hospitals NHS Trust, Atomedical (Portugal), National Institute for Medical Research, University of Birmingham, Medical Research Council

OpenAlex ID: A5025087847

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

2009 · David Bending, Hugo De La Peña, et al. · Journal of Clinical Investigation · 558

MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

2013 · Mark Cobbold, Hugo De La Peña, et al. · Science Translational Medicine · 205

Quantum Dots and Carbon Nanotubes in Oncology: A Review on Emerging Theranostic Applications in Nanomedicine

2011 · Aaron Tan, Lara Yildirimer, et al. · Nanomedicine · 122

Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations

2009 · Jenny M. Phillips, Nicole M. Parish, et al. · The Review of Diabetic Studies · 108

PDF

Artificial exosomes as tools for basic and clinical immunology

2009 · Hugo De La Peña, J.A. Madrigal, et al. · Journal of Immunological Methods · 90

Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK

2018 · Robert A. Watson, Hugo De La Peña, et al. · British Journal of Cancer · 64

PDF

Anti-PD-L1 atezolizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Literature

2017 · Laura Hickmott, Hugo De La Peña, et al. · Targeted Oncology · 48

No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer

2017 · H. De La Pena, A. Sharma, et al. · European Journal of Cancer · 38

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

2025 · Silke Gillessen, Laura Murphy, et al. · The Lancet Oncology · 29

PDF

Roles for TGF-β and Programmed Cell Death 1 Ligand 1 in Regulatory T Cell Expansion and Diabetes Suppression by Zymosan in Nonobese Diabetic Mice

2010 · Oliver T Burton, Paola Zaccone, et al. · The Journal of Immunology · 25

PDF

The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

2009 · Mark Tuthill, Frederick Chen, et al. · Cancer Immunology Immunotherapy · 20

PDF

Human Polyclonal Immunoglobulin Labelled with Technetium-99m via NHS-MAG3: A Comparison of Radiochemical Behavior and Biological Efficacy with Other Labelling Methods

1998 · L Gano, L Patrı́cio, et al. · Nuclear Medicine and Biology · 12

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5

Pulmonary tumour thrombotic microangiopathy mimicking immunotherapy-associated pneumonitis

2023 · Hayley McKenzie, Deborah Scott, et al. · BMJ Case Reports · 2

Left arm position - effect of attenuation correction on myocardial tracer distribution

1999 · G Cantinho, H Pena, et al. · Journal of Nuclear Cardiology · 2

Stratified follow-up pathways for cancer patients

2019 · Hugo De La Peña · Clinical Medicine · 1

3.12

2007 · G. Cantinho, H. Pena, et al. · Journal of Nuclear Cardiology · 1

Hemato Nanotechnology: Artificial APC System for T Cell Adoptive and Active Immunotherapy.

2005 · H. De La Pena, J. A. Madrigal, et al. · Blood · 1

Technetium-99m Labelling of the IOR CEA 1 Monoclonal Antibody: Evaluation of Different Methods

1997 · L. Gano, C. Fernandes, et al. · Nuklearmedizin - NuclearMedicine · 1

Abstract 2893: Engineered release and presentation of antibody-bound viral antigens: A highly specific and novel immunotherapeutic approach to target cancer in vivo

2014 · David G. Millar, Laura Morton, et al. · Cancer Research

Perioperative Chemotherapy in Oesophageal Cancer Patients: Regional Single Centre Experience

2013 · Hugo De La Pena, Victoria Kunene · Annals of Oncology

Abstract 512: Leukemia-specific immunity in healthy individuals and patients post-transplant targets phosphorylated tumor antigens

2012 · Hugo De La Peña, James E. Turner, et al. · Cancer Research

Immunologically Targeting the Leukaemia Phosphoproteome

2010 · Hugo De La Peña, Thomas Butler, et al. · Blood

TH17 cells cause diabetes in a NOD environment by converting to TH1 cells

2008 · Hugo De La Peña, David Bending, et al. · UCL Discovery (University College London)

Development of a novel nanotechnology based artificial antigen presenting cell system for adoptive and active immunotherapy

2007 · Hugo De La Peña · Doctoral thesis, UCL (University College London).

Works count: 28

Citation count: 1,332

H-index: 12

I10-index: 12